From 1016 opportunities to ΔG-visualization in the binding site

webinar

Thu, 26 Oct 2017, 14:00 CEST (Berlin)

Dr. Christian Lemmen, BioSolveIT GmbH, St. Augustin, Germany

From 1016 opportunities to ΔG-visualization in the binding site

Taking “the best of both worlds” is usually desirable but rarely achieveable in real life. In drug discovery it is worse: many solutions — so many choices — but no one software can handle all challenges equally well.
Workflow systems like KNIME® offer you a single interface to a myriad of tools and help you to organize, standardize, and streamline your approach and be best prepared all along the way from 1016 opportunities to visualizing atom-based ΔG-contributions in the binding site. We will show you a number of highly efficient strategies implemented this way. Plus you’ll get those as a blue print for your own solution.

Current news

category
Events
Recordings of the BioSolveIT Day 2025 Available
October 15, 2025 13:39 CEST
Missed BioSolveIT Day 2025? The recordings from BioSolveIT Day 2025 are now live! Packed with practical insights for medicinal and computational chemists, the sessions showcase how SeeSAR, infiniSee, Chemical Space Docking®, and CoLibri accelerate real-world discovery, from pocket-aware design and HYDE-guided decisions to trillion-scale, synthesizable chemical space exploration and in-house...
Read on
Enamine’s REAL Space September 2025 Update - Now 83 Billion!
September 23, 2025 10:31 CEST
The September 2025 update of Enamine’s REAL Space brings a new expansion, now featuring over 83 billion accessible, drug-like products, up from 76 billion in the previous release. Built from 172 curated reactions and 192,487 reagents and building blocks based on in-house knowledge, this version further enhances one of the...
Read on
WuXi’s GalaXi Space September 2025 – Expanded to 26 Billion Molecules!
September 17, 2025 10:03 CEST
The September 2025 update of WuXi LabNetwork’s GalaXi Space delivers a major expansion, now featuring over 25.8 billion synthesis-ready products. Built from 185 curated reactions and 30,877 high-quality building blocks, GalaXi is one of the largest tangible Chemical Spaces for modern drug discovery. This release broadens structural diversity with novel...
Read on